Literature DB >> 18520835

Basal cell carcinoma of the eyelids and periorbital region in a Turkish population.

Hülya Gökmen Soysal1, Ergin Soysal, Fatma Markoç, Fisun Ardiç.   

Abstract

PURPOSE: To review the clinical and histopathologic features, treatment, and outcomes of eyelid basal cell carcinomas.
METHODS: The clinical records and histopathologic specimens of 311 patients with eyelid basal cell carcinomas were reviewed and analyzed retrospectively. The main outcome measures are patient demographics, clinical characteristics, lesion size, duration of lesion, histologic subtypes, presence of orbital and perineural invasion, severity of peritumorous inflammation, treatment modalities, recurrence rate, tumor-related death, and prognostic features.
RESULTS: Two-hundred ninety patients underwent surgery whereas others received radiotherapy or chemotherapy. The most common histologic subtypes were infiltrative, nodular, and basosquamous basal cell carcinomas. Nearly one-third (29.9%) of the patients were previously recurrent. Orbital and perineural invasion rates were 17.04% and 10.6%, respectively. Recurrent basal cell carcinomas were larger, with longer duration of lesion and a higher rate of orbital and perineural invasion. Basosquamous basal cell carcinomas were more likely to have prior recurrences, larger lesion size, and the highest rate of orbital invasion. Perineural invasion was most frequent in morpheaform and basosquamous subtypes. Peritumorous inflammation differed between subtypes and was highest in the superficial subtype. The recurrence rate was 7.39% in total. The death of 2 patients was tumor-related.
CONCLUSIONS: In this large case series from a single center, the outcomes were worse than previously reported due to delay in treatment and previous inadequate treatments. Adverse prognostic factors associated with secondary orbital invasion are previous recurrences, aggressive histologic subtypes, longer duration of lesion, larger lesion size, and the presence of perineural invasion.

Entities:  

Mesh:

Year:  2008        PMID: 18520835     DOI: 10.1097/IOP.0b013e31816d954d

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  5 in total

1.  [Comparison of the aesthetic outcome and complication rate of reconstructive surgical procedures of the eyelid after basalioma excision].

Authors:  V Engelmann; S Pfrommer; M J Dridi; J Piening; C P Lohmann; R-L Merté
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

2.  [Basal cell carcinoma of the periocular region].

Authors:  F Geszti; D Hargitai; O Lukáts; H Győrffy; J Tóth
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

3.  Efficacy of Vismodegib (Erivedge) for Basal Cell Carcinoma Involving the Orbit and Periocular Area.

Authors:  Hakan Demirci; Francis Worden; Christine C Nelson; Victor M Elner; Alon Kahana
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 Nov-Dec       Impact factor: 1.746

4.  Regression of Periocular Basal Cell Carcinoma: A Report of Four Cases with Clinicopathologic Correlation.

Authors:  Martina C Herwig-Carl; Karin U Loeffler
Journal:  Ocul Oncol Pathol       Date:  2019-08-28

5.  The immunoexpression of MMP-1 and MMP-13 in eyelid basal cell carcinoma.

Authors:  Irina Maria Mercuţ; Cristiana Eugenia Simionescu; Alex Emilian Stepan; Bianca Cătălina Andreiana; Ana Maria Ciurea; Răzvan Mercuţ; Marius Eugen Ciurea
Journal:  Rom J Morphol Embryol       Date:  2020 Oct-Dec       Impact factor: 1.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.